This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 1103 |
| PCR | 835 |
| China | 833 |
| H1N1 | 678 |
| COVID-19 | 525 |
| A | 512 |
| RSV | 442 |
| Health | 418 |
| Fig | 386 |
| ICU | 375 |
| S. | 375 |
| Table | 358 |
| Hong | 325 |
| MERS | 322 |
| Kong | 319 |
| CoV | 313 |
| RT | 305 |
| M. | 289 |
| CoV-2 | 285 |
| C | 284 |
| Hospital | 259 |
| HIV | 251 |
| RNA | 247 |
| CI | 246 |
| T | 242 |
| US | 236 |
| B | 234 |
| January | 224 |
| H7N9 | 221 |
| Influenza | 219 |
| MRSA | 211 |
| University | 204 |
| Dis | 199 |
| USA | 188 |
| BMC | 183 |
| CT | 182 |
| Taiwan | 176 |
| ARDS | 169 |
| National | 169 |
| ILI | 163 |
| United | 162 |
| Wuhan | 159 |
| TB | 159 |
| CMV | 156 |
| II | 153 |
| H5N1 | 151 |
| Germany | 149 |
| States | 147 |
| Control | 144 |
| ECMO | 143 |
| Disease | 140 |
| World | 139 |
| IgM | 136 |
| Canada | 136 |
| Province | 135 |
| East | 135 |
| CDC | 134 |
| March | 134 |
| Medical | 131 |
| February | 130 |
| Group | 128 |
| April | 127 |
| July | 122 |
| September | 121 |
| Organization | 121 |
| Beijing | 120 |
| HAdV | 120 |
| May | 117 |
| SD | 116 |
| December | 116 |
| • | 114 |
| Research | 114 |
| Staphylococcus | 113 |
| Prevention | 111 |
| ELISA | 109 |
| HBoV | 109 |
| Middle | 107 |
| June | 107 |
| mg | 106 |
| Saudi | 106 |
| IgG | 105 |
| IFN | 103 |
| Committee | 103 |
| B. | 103 |
| Center | 102 |
| PICU | 99 |
| Arabia | 99 |
| parainfluenza | 97 |
| November | 97 |
| Japan | 96 |
| ± | 94 |
| Q | 94 |
| ARI | 93 |
| DNA | 93 |
| sha | 92 |
| Korea | 92 |
| HIV-1 | 89 |
| C. | 88 |
| South | 87 |
| Institute | 87 |
| M | 85 |
| Central | 84 |
| Singapore | 84 |
| Department | 83 |
| VSB | 82 |
| TNF | 82 |
| FilmArray | 82 |
| Africa | 82 |
| Guangzhou | 81 |
| E. | 81 |
| Infectious | 80 |
| L | 80 |
| PUE | 80 |
| Respiratory | 80 |
| Coronavirus | 78 |
| City | 78 |
| meta | 77 |
| Springer | 77 |
| Ethics | 77 |
| Dengue | 77 |
| Australia | 77 |
| August | 76 |
| Nature | 75 |
| NTM | 75 |
| HPIV | 75 |
| γ | 74 |
| Evaluation | 74 |
| Diseases | 74 |
| Human | 73 |
| Europe | 73 |
| Toxocara | 73 |
| Typhi | 72 |
| H5N2 | 72 |
| CFU | 72 |
| < | 72 |
| WHO | 72 |
| hBoV | 71 |
| IQR | 71 |
| F | 70 |
| AI | 70 |
| International | 70 |
| HCWs | 70 |
| NPI | 70 |
| Index | 69 |
| HA | 69 |
| FRI | 69 |
| Italy | 68 |
| IFA | 68 |
| System | 68 |
| SPSS | 68 |
| ARTI | 67 |
| HPAI | 67 |
| α | 66 |
| Association | 66 |
| Brisbane | 66 |
| Rickettsia | 65 |
| Care | 65 |
| HKU1 | 65 |
| HPS | 64 |
| HAdV-3 | 64 |
| AOR | 64 |
| UK | 63 |
| Surveillance | 63 |
| Schistosoma | 63 |
| Mycoplasma | 63 |
| Hubei | 63 |
| 63 | |
| CRP | 63 |
| Hepatitis | 62 |
| Acinetobacter | 62 |
| HFRS | 62 |
| New | 62 |
| UTI | 62 |
| OC43 | 62 |
| URTI | 61 |
| EV | 61 |
| RVP | 60 |
| HRV | 60 |
| HFMD | 60 |
| HCoV | 60 |
| Chinese | 60 |
| BALF | 60 |
| NL63 | 59 |
| ADV | 59 |
| EOPM | 59 |
| EV71 | 59 |
| October | 59 |
| RDT | 59 |
| Sichuan | 59 |
| Shanghai | 59 |
| Review | 58 |
| Mexico | 58 |
| H3N2 | 58 |
| pH1N1 | 57 |
| A2063 | 57 |
| G | 56 |
| CA | 56 |
| North | 55 |
| BMI | 55 |
| Iran | 55 |
| Asia | 55 |
| Public | 55 |
| SSI | 55 |
| Wang | 55 |
| MDRGN | 54 |
| France | 54 |
| Analysis | 54 |
| A(H1N1)pdm09 | 54 |
| APACHE | 53 |
| Children | 53 |
| Fisher | 53 |
| R. | 53 |
| U. | 53 |
| POC | 52 |
| PBS | 52 |
| Medicine | 52 |
| Liu | 52 |
| Clinical | 52 |
| Centers | 51 |
| Alere | 51 |
| Salmonella | 51 |
| Virus | 51 |
| piperacillin | 50 |
| Society | 50 |
| S1 | 50 |
| Netherlands | 50 |
| NS1 | 50 |
| ISA | 50 |
| E | 50 |
| D | 50 |
| B55 | 50 |
| metapneumovirus | 50 |
| HAdV-7 | 49 |
| ED | 49 |
| pranobex | 49 |
| Ministry | 49 |
| T. | 49 |
| America | 48 |
| Diagnostics | 48 |
| LAMP | 48 |
| Figure | 48 |
| HLA | 48 |
| Inc. | 48 |
| U | 48 |
| MHC | 48 |
| Qiagen | 48 |
| Streptococcus | 48 |
| inosine | 48 |
| Viral | 48 |
| bocavirus | 47 |
| baumannii | 47 |
| S | 47 |
| RANTES | 47 |
| Note | 47 |
| Moran | 46 |
| Laboratory | 46 |
| Montanide | 45 |
| catarrhalis | 45 |
| Qinghai | 45 |
| MH | 44 |
| COPD | 44 |
| AIDS | 44 |
| Syndrome | 43 |
| Sri | 43 |
| Science | 43 |
| ROC | 43 |
| PIV4 | 43 |
| PI | 43 |
| N | 43 |
| Li | 43 |
| I | 43 |
| Brazil | 43 |
| District | 42 |
| HAI | 42 |
| Moraxella | 42 |
| Spain | 42 |
| gondii | 42 |
| Thailand | 42 |
| Pandemic | 41 |
| AUC | 41 |
| CD4 | 41 |
| Institutional | 41 |
| GLEaMviz | 41 |
| People | 41 |
| Republic | 41 |
| Study | 41 |
| VAP | 41 |
| LPAI | 40 |
| Adenovirus | 40 |
| Centre | 40 |
| DF | 40 |
| Epidemiology | 40 |
| European | 40 |
| RespiFinder | 40 |
| NIMCU | 40 |
| Pseudomonas | 40 |
| R | 40 |
| typhi | 40 |
| PZQ | 40 |
| PX | 39 |
| DV | 39 |
| Global | 39 |
| OV | 39 |
| RPA | 39 |
| RespiFinder-19 | 39 |
| Zhejiang | 39 |
| sera | 39 |
| Dr. | 38 |
| ARIMA | 38 |
| Chi | 38 |
| College | 38 |
| N95 | 38 |
| EDs | 38 |
| NIV | 38 |
| PIV | 38 |
| Russia | 38 |
| Roche | 37 |
| CD8 | 37 |
| Acute | 37 |
| MADs | 36 |
| CAA | 36 |
| DFA | 36 |
| Enterococcus | 36 |
| Escherichia | 36 |
| GenBank | 36 |
| HAdVs | 36 |
| Lanka | 36 |
| Infection | 36 |
| MD | 36 |
| Toxascaris | 36 |
| Zhang | 36 |
| VRE | 36 |
| kg | 36 |
| OP | 36 |
| Novel | 36 |
| MS | 36 |
| ERV3 | 35 |
| EBV | 35 |
| Development | 35 |
| Detection | 35 |
| Commission | 35 |
| Board | 35 |
| A. | 35 |
| lymphopenia | 35 |
| Guideline | 34 |
| General | 34 |
| LF | 34 |
| CAP | 33 |
| Yang | 33 |
| U.S. | 33 |
| Poisson | 33 |
| Molecular | 33 |
| MP | 33 |
| LC | 33 |
| Indonesia | 33 |
| tsutsugamushi | 33 |
| Bordetella | 33 |
| BioMed | 33 |
| BACKGROUND | 33 |
| Data | 32 |
| H. | 32 |
| IV | 32 |
| Community | 32 |
| IL-10 | 32 |
| Roma | 32 |
| LRTI | 32 |
| henselae | 32 |
| TAF | 32 |
| burnetii | 32 |
| Nepal | 32 |
| KIPyV | 31 |
| Bartonella | 31 |
| Hajj | 31 |
| IL-6 | 31 |
| Network | 31 |
| MIS | 31 |
| Stenotrophomonas | 31 |
| UCP | 31 |
| VP1 | 31 |
| P. | 30 |
| FluA | 30 |
| Malaysia | 30 |
| Invitrogen | 30 |
| PTB | 30 |
| Parainfluenza | 30 |
| TREM-1 | 30 |
| NP | 29 |
| Applied | 29 |
| Assessment | 29 |
| Chen | 29 |
| Management | 29 |
| Ethiopia | 29 |
| PPV | 29 |
| RKI | 29 |
| ViroTrack | 29 |
| hMPV | 29 |
| nonliquefaciens | 29 |
| PMTCT | 28 |
| AR | 28 |
| Cameroon | 28 |
| Healthcare | 28 |
| L. | 28 |
| Lyantonde | 28 |
| OPS | 28 |
| Whitney | 28 |
| RP | 28 |
| RV | 28 |
| SAS | 28 |
| SLR | 28 |
| WBC | 28 |
| hepatitis | 28 |
| CRs | 27 |
| Chongqing | 27 |
| DVV | 27 |
| Flu | 27 |
| Kingdom | 27 |
| Mann | 27 |
| Panel | 27 |
| Program | 27 |
| PubMed | 27 |
| Sciences | 27 |
| Transmission | 27 |
| Uganda | 27 |
| cefepime | 27 |
| linezolid | 27 |
| Emergency | 26 |
| England | 26 |
| FB | 26 |
| NPV | 26 |
| IPPV | 26 |
| NK | 26 |
| Government | 26 |
| Pearson | 26 |
| QIAamp | 26 |
| RH | 26 |
| UV | 26 |
| maltophilia | 26 |
| mef(A | 26 |
| Pure | 26 |
| ID | 25 |
| 2DRA | 25 |
| Airport | 25 |
| Antimicrobial | 25 |
| Appendix | 25 |
| ELECTRONIC | 25 |
| Jiangxi | 25 |
| Kadoma | 25 |
| MASP2 | 25 |
| PV | 25 |
| Pneumonia | 25 |
| State | 25 |
| West | 25 |
| virus | 25 |
| MAT | 24 |
| CG | 24 |
| HLH | 24 |
| ICUs | 24 |
| IL-4 | 24 |
| India | 24 |
| JS | 24 |
| Chlamydia | 24 |
| MagNA | 24 |
| SMART-22 | 24 |
| Services | 24 |
| Statistical | 24 |
| sTREM-1 | 24 |
| TS | 24 |
| Orientia | 24 |
| J. | 23 |
| Report | 23 |
| Rapid | 23 |
| Publisher | 23 |
| Cytomegalovirus | 23 |
| IL-1β | 23 |
| HCW | 23 |
| School | 23 |
| Biosystems | 23 |
| Bioline | 23 |
| S2 | 23 |
| Risk | 23 |
| Shandong | 23 |
| multicentre | 23 |
| Spearman | 23 |
| viridans | 23 |
| tazobactam | 23 |
| rD6 | 23 |
| ® | 23 |
| mL | 23 |
| colistin | 23 |
| Team | 23 |
| Stata | 23 |
| Anaplasma | 22 |
| Barr | 22 |
| Bio | 22 |
| Candida | 22 |
| ESKAPE+C | 22 |
| Ebola | 22 |
| Gabon | 22 |
| Narita | 22 |
| MDR | 22 |
| MIP-1β | 22 |
| MBL | 22 |
| O. | 22 |
| Use | 22 |
| influenza | 22 |
| der | 22 |
| York | 22 |
| PIV3 | 22 |
| Ureaplasma | 22 |
| Trends | 22 |
| Safety | 22 |
| Patient | 22 |
| PaO | 21 |
| A1 | 21 |
| BOS | 21 |
| Chicago | 21 |
| Guidelines | 21 |
| HIDs | 21 |
| K. | 21 |
| Lazio | 21 |
| Ltd. | 21 |
| MPP | 21 |
| nan | 21 |
| NGS | 21 |
| mofetil | 21 |
| Richards | 21 |
| Senegal | 21 |
| Zengdu | 21 |
| bp | 21 |
| cati | 21 |
| doc_id | 21 |
| rRNA | 21 |
| oseltamivir | 21 |
| rE4 | 21 |
| Qatar | 21 |
| HPIV-3 | 20 |
| HPIV-1 | 20 |
| Klebsiella | 20 |
| Helsinki | 20 |
| EpiGraph | 20 |
| Epstein | 20 |
| Berlin | 20 |
| DHS | 20 |
| Corporation | 20 |
| CoV. | 20 |
| Bureau | 20 |
| Infections | 20 |
| Yu | 20 |
| MR | 20 |
| Western | 20 |
| Mycobacterium | 20 |
| pandemic | 20 |
| disease | 20 |
| bPI | 20 |
| https://doi.org/10 | 20 |
| Statistics | 20 |
| Office | 20 |
| Niger | 20 |
| NPA | 20 |
| DAI | 19 |
| Information | 19 |
| Impact | 19 |
| I. | 19 |
| Hilden | 19 |
| FIB | 19 |
| Enterobacteriaceae | 19 |
| Declaration | 19 |
| American | 19 |
| Ct | 19 |
| Case | 19 |
| CSF | 19 |
| Arkhangelsk | 19 |
| A(H1N1 | 19 |
| 16S | 19 |
| Knowledge | 19 |
| Kenya | 19 |
| RTI | 19 |
| MCP-1 | 19 |
| Service | 19 |
| Measles | 19 |
| rH6 | 19 |
| amoxicillin | 19 |
| Unit | 19 |
| URI | 19 |
| Sinti | 19 |
| mm | 19 |
| Scopus | 19 |
| β | 19 |
| QLD-01 | 19 |
| Nosocomial | 19 |
| NPS | 19 |
| Model | 19 |
| SAR | 19 |
| Haemophilus | 18 |
| PPE | 18 |
| Lee | 18 |
| IRB | 18 |
| IPD | 18 |
| ARIwC | 18 |
| Guangdong | 18 |
| Eastern | 18 |
| Australian | 18 |
| ACE | 18 |
| SV40 | 18 |
| Rhinovirus | 18 |
| SENLAT | 18 |
| parvum | 18 |
| Station | 18 |
| TMP | 18 |
| TX | 18 |
| Technology | 18 |
| Vietnam | 18 |
| Wu | 18 |
| Zhou | 18 |
| mycophenolate | 18 |
| van | 18 |
| μg | 18 |
| Soest | 18 |
| H3 | 17 |
| Foundation | 17 |
| Fund | 17 |
| H | 17 |
| IL | 17 |
| HCoVs | 17 |
| HMPV | 17 |
| Day | 17 |
| Fast | 17 |
| Army | 17 |
| DHF | 17 |
| Co. | 17 |
| California | 17 |
| CV | 17 |
| CP | 17 |
| ANOVA | 17 |
| A/ | 17 |
| III | 17 |
| Diagnostic | 17 |
| Intensive | 17 |
| Scholar | 17 |
| st | 17 |
| hCoV | 17 |
| Y | 17 |
| Wei | 17 |
| Wales | 17 |
| VTM | 17 |
| Survey | 17 |
| Social | 17 |
| Koch | 17 |
| tenofovir | 17 |
| Resistance | 17 |
| RR | 17 |
| Population | 17 |
| Northern | 17 |
| Microbiology | 17 |
| MM | 17 |
| Riyadh | 17 |
| Leptospira | 16 |
| J | 16 |
| LDH | 16 |
| Ontario | 16 |
| Linyi | 16 |
| MVI | 16 |
| Mini | 16 |
| FluB | 16 |
| HRCT | 16 |
| County | 16 |
| Epidemic | 16 |
| English | 16 |
| Effectiveness | 16 |
| Cochrane | 16 |
| CNS | 16 |
| BD | 16 |
| Affiliated | 16 |
| Project | 16 |
| ANC | 16 |
| Plan | 16 |
| Reference | 16 |
| association | 16 |
| Rome | 16 |
| penton | 16 |
| pH | 16 |
| ml | 16 |
| mid | 16 |
| group | 16 |
| chi | 16 |
| bronchoalveolar | 16 |
| lactam | 16 |
| Zhao | 16 |
| Software | 16 |
| Working | 16 |
| SMO | 16 |
| SMX | 16 |
| S3 | 16 |
| Time | 16 |
| WU | 16 |
| Hygiene | 15 |
| MNM | 15 |
| Lu | 15 |
| Log | 15 |
| Lin | 15 |
| Legionella | 15 |
| Kim | 15 |
| Investigation | 15 |
| IC | 15 |
| IBM | 15 |
| CAS | 15 |
| Hebei | 15 |
| French | 15 |
| First | 15 |
| Federal | 15 |
| Factors | 15 |
| FLU | 15 |
| CLABSI | 15 |
| CAUTI | 15 |
| OTC | 15 |
| Microsoft | 15 |
| KC | 15 |
| Polymerase | 15 |
| Xu | 15 |
| qPCR | 15 |
| metagenomic | 15 |
| lymphohistiocytosis | 15 |
| i | 15 |
| health | 15 |
| cytomegalovirus | 15 |
| committee | 15 |
| Ying | 15 |
| YW | 15 |
| Region | 15 |
| Wilcoxon | 15 |
| Vaccine | 15 |
| review | 15 |
| Survival | 15 |
| Struvite | 15 |
| San | 15 |
| SISSS | 15 |
| Respir | 15 |
| Regional | 15 |
| Vi | 15 |
| Eq | 14 |
| D. | 14 |
| ECG | 14 |
| Efficacy | 14 |
| Homes | 14 |
| GM | 14 |
| GRO | 14 |
| HBV | 14 |
| HCP | 14 |
| Copan | 14 |
| Cq | 14 |
| Anhui | 14 |
| CK | 14 |
| CASE | 14 |
| Blood | 14 |
| Authority | 14 |
| Agency | 14 |
| AST | 14 |
| ABI | 14 |
| A(H7N9 | 14 |
| 8) | 14 |
| Immunization | 14 |
| IP-10 | 14 |
| Huang | 14 |
| Kulldorff | 14 |
| Paratyphi | 14 |
| polyomavirus | 14 |
| doi:10.1186 | 14 |
| bang | 14 |
| Tuberculosis | 14 |
| Tianjin | 14 |
| STATA | 14 |
| SARI | 14 |
| Robert | 14 |
| Protection | 14 |
| Pediatric | 14 |
| SNPs | 14 |
| Panton | 14 |
| OR | 14 |
| OIDD | 14 |
| Neisseria | 14 |
| NS | 14 |
| Maela | 14 |
| Luminex | 14 |
| Lau | 14 |
| LRT | 14 |
| PLC | 14 |
| HPIV-2 | 13 |
| Food | 13 |
| GP | 13 |
| Guiana | 13 |
| HFNC | 13 |
| Mekelle | 13 |
| King | 13 |
| Lung | 13 |
| Lyon | 13 |
| Meta | 13 |
| Emerg | 13 |
| FTD | 13 |
| ARV | 13 |
| EN | 13 |
| ELISPOT | 13 |
| Duo | 13 |
| Council | 13 |
| Chan | 13 |
| CXR | 13 |
| CCA | 13 |
| Biotechnology | 13 |
| Bavaria | 13 |
| Adults | 13 |
| Ms. | 13 |
| ALT | 13 |
| Michael | 13 |
| Xiao | 13 |
| NY | 13 |
| W | 13 |
| OLFM4 | 13 |
| ≥65 | 13 |
| ≤ | 13 |
| −80 | 13 |
| vivo | 13 |
| qRT | 13 |
| ij | 13 |
| doxycycline | 13 |
| azithromycin | 13 |
| X | 13 |
| Wen | 13 |
| zur | 13 |
| Valentine | 13 |
| Scientific | 13 |
| Outbreak | 13 |
| VC | 13 |
| PRAE | 13 |
| SHAP | 13 |
| Pyridostigmine | 13 |
| Southeast | 13 |
| Standards | 13 |
| Studies | 13 |
| Tang | 13 |
| GG | 12 |
| Hemisphere | 12 |
| GGO | 12 |
| GI | 12 |
| Geneva | 12 |
| German | 12 |
| H1N1/2009 | 12 |
| HH | 12 |
| INF | 12 |
| IDSA | 12 |
| IIDs | 12 |
| IL-8 | 12 |
| IVIG | 12 |
| Ixodes | 12 |
| JC | 12 |
| FiO | 12 |
| Jiangsu | 12 |
| CC | 12 |
| Fever | 12 |
| Emergence | 12 |
| +874A | 12 |
| AB | 12 |
| Action | 12 |
| Bonferroni | 12 |
| C57 | 12 |
| CFR | 12 |
| CR | 12 |
| CUHK | 12 |
| Cape | 12 |
| Characteristics | 12 |
| Chlamydophila | 12 |
| Covid-19 | 12 |
| Denmark | 12 |
| Diagnosis | 12 |
| Division | 12 |
| JW | 12 |
| STARD | 12 |
| K | 12 |
| Suzhou | 12 |
| Taq | 12 |
| TaqMan | 12 |
| Thoracic | 12 |
| Treatment | 12 |
| Turkey | 12 |
| UniFrac | 12 |
| Utah | 12 |
| V. | 12 |
| WGS | 12 |
| cells-1 | 12 |
| cfu | 12 |
| min | 12 |
| series | 12 |
| − | 12 |
| KI | 12 |
| Switzerland | 12 |
| Virology | 12 |
| StataCorp | 12 |
| Organisation | 12 |
| Southern | 12 |
| LR | 12 |
| Laboratories | 12 |
| MA | 12 |
| Mediterranean | 12 |
| NHSN | 12 |
| Malaria | 12 |
| PVL | 12 |
| Prism | 12 |
| Quarantine | 12 |
| Reporting | 12 |
| ResPECT | 12 |
| PMS | 12 |
| SDS | 12 |
| Drs | 11 |
| Feng | 11 |
| GraphPad | 11 |
| Genome | 11 |
| Fuyang | 11 |
| Ethical | 11 |
| FN | 11 |
| FCS | 11 |
| H7 | 11 |
| H1 | 11 |
| Joint | 11 |
| HCoV-229E | 11 |
| HGA | 11 |
| HID | 11 |
| HPIV-4 | 11 |
| Identification | 11 |
| IgG2a | 11 |
| Jin | 11 |
| Jun | 11 |
| Cross | 11 |
| Dickinson | 11 |
| AG | 11 |
| Cox | 11 |
| ArcGIS | 11 |
| 23S | 11 |
| ACE2 | 11 |
| ACh | 11 |
| Latin | 11 |
| Advisory | 11 |
| Ag | 11 |
| Animal | 11 |
| Ankara | 11 |
| Assay | 11 |
| Comparison | 11 |
| Avian | 11 |
| Becton | 11 |
| Bocavirus | 11 |
| Borrelia | 11 |
| C.I | 11 |
| C1 | 11 |
| Cambodia | 11 |
| Colombo | 11 |
| Lake | 11 |
| LP | 11 |
| London | 11 |
| XZ | 11 |
| ZW | 11 |
| aOR | 11 |
| agalactiae | 11 |
| arthralgia | 11 |
| author(s | 11 |
| bronchiolitis | 11 |
| enterica | 11 |
| fm | 11 |
| hemophagocytic | 11 |
| hexon | 11 |
| kDa | 11 |
| kb | 11 |
| lymphocytopenia | 11 |
| monocyte | 11 |
| monoplex | 11 |
| nTREM-1 | 11 |
| nvHAP | 11 |
| square | 11 |
| × | 11 |
| Yunnan | 11 |
| national | 11 |
| Windows | 11 |
| Pan | 11 |
| Welfare | 11 |
| MNV | 11 |
| Maripa | 11 |
| Ni | 11 |
| Oseltamivir | 11 |
| PCV-13 | 11 |
| Pacific | 11 |
| Pakistan | 11 |
| MEGA | 11 |
| Physiology | 11 |
| Practices | 11 |
| Predictors | 11 |
| SNP | 11 |
| Scotland | 11 |
| TDF | 11 |
| Thai | 11 |
| Plasmodium | 11 |
| Viruses | 11 |
| Huzhou | 10 |
| HI | 10 |
| HR | 10 |
| Han | 10 |
| Hemophagocytic | 10 |
| Hu | 10 |
| Hui | 10 |
| Inc | 10 |
| I(2 | 10 |
| ICF | 10 |
| IL-18 | 10 |
| Greece | 10 |
| Institut | 10 |
| Jingzhou | 10 |
| Kit | 10 |
| MOI | 10 |
| MTCT | 10 |
| H5 | 10 |
| Estimation | 10 |
| G. | 10 |
| Chest | 10 |
| Mr. | 10 |
| AV | 10 |
| Abbott | 10 |
| B11 | 10 |
| BioFire | 10 |
| C3a | 10 |
| CCS2 | 10 |
| Chronic | 10 |
| Finland | 10 |
| Complement | 10 |
| Coxiella | 10 |
| ERY | 10 |
| Egypt | 10 |
| Entero | 10 |
| Excel | 10 |
| F. | 10 |
| Monitoring | 10 |
| Wenzhou | 10 |
| NICU | 10 |
| Würzburg | 10 |
| Systems | 10 |
| Thermo | 10 |
| Tokyo | 10 |
| Track | 10 |
| Tropical | 10 |
| WH | 10 |
| Wallis | 10 |
| Yan | 10 |
| Shigella | 10 |
| Zimbabwe | 10 |
| enteroviruses | 10 |
| inotropic | 10 |
| mmHg | 10 |
| stay | 10 |
| von | 10 |
| Nagasaki | 10 |
| Sun | 10 |
| miss | 10 |
| Seoul | 10 |
| Queensland | 10 |
| Norway | 10 |
| Sentinel | 10 |
| ORF1ab | 10 |
| PRISMA | 10 |
| Package | 10 |
| Ping | 10 |
| QAV | 10 |
| POST | 10 |
| RM | 10 |
| Sanger | 10 |
| Russian | 10 |
| S4 | 10 |
| Scrub | 10 |
| SIR | 10 |
| SP | 10 |
| RPD | 10 |
| Infusion | 9 |
| Illness | 9 |
| IU | 9 |
| IPC | 9 |
| IL-2 | 9 |
| IHD | 9 |
| HepG2 | 9 |
| IFVs | 9 |
| Hib | 9 |
| Gansu | 9 |
| GLEaM | 9 |
| Fullerton | 9 |
| Jeddah | 9 |
| Family | 9 |
| JZ | 9 |
| Maternal | 9 |
| Jing | 9 |
| KS | 9 |
| Kawasaki | 9 |
| Kruskal | 9 |
| LLR | 9 |
| Leishmania | 9 |
| Mary | 9 |
| Mecca | 9 |
| MicrosensDx | 9 |
| Ming | 9 |
| Monte | 9 |
| Multiplex | 9 |
| Municipal | 9 |
| FDA | 9 |
| FDC | 9 |
| CIs | 9 |
| FAM | 9 |
| EuroNHID | 9 |
| NCBI | 9 |
| 2D | 9 |
| 2b | 9 |
| ASP | 9 |
| ATS | 9 |
| AZM | 9 |
| Activation | 9 |
| Al | 9 |
| Americas | 9 |
| Argentina | 9 |
| Bin | 9 |
| Box | 9 |
| C2 | 9 |
| Cao | 9 |
| Carlo | 9 |
| Chain | 9 |
| Committees | 9 |
| Correlation | 9 |
| Criteria | 9 |
| DNASTAR | 9 |
| David | 9 |
| De | 9 |
| Dr | 9 |
| EC | 9 |
| ECDC | 9 |
| Editor | 9 |
| Enterovirus | 9 |
| Epi | 9 |
| Epidemiologic | 9 |
| Myanmar | 9 |
| Response | 9 |
| ND | 9 |
| Swine | 9 |
| Tan | 9 |
| Testing | 9 |
| Torres | 9 |
| Town | 9 |
| Toxoplasma | 9 |
| Trial | 9 |
| Type | 9 |
| Valencia | 9 |
| Van | 9 |
| Veterinary | 9 |
| Wong | 9 |
| XL | 9 |
| Yi | 9 |
| Zheng | 9 |
| Zurich | 9 |
| analysis | 9 |
| board | 9 |
| conorii | 9 |
| coryza | 9 |
| echovirus | 9 |
| ganciclovir | 9 |
| levofloxacin | 9 |
| mITT | 9 |
| mTREM-1 | 9 |
| rRT | 9 |
| trimethoprim | 9 |
| ward | 9 |
| ° | 9 |
| NIH | 9 |
| Tables | 9 |
| Zealand | 9 |
| Sweden | 9 |
| Patients | 9 |
| Stephen | 9 |
| NRTI | 9 |
| Nacional | 9 |
| Nations | 9 |
| NetMHCpan4.0 | 9 |
| Newcastle | 9 |
| Ng | 9 |
| Number | 9 |
| Ottawa | 9 |
| PCT | 9 |
| PIV-2 | 9 |
| PLTC | 9 |
| PS | 9 |
| Pasteur | 9 |
| NO | 9 |
| Peru | 9 |
| Royal | 9 |
| Shenyang | 9 |
| Severe | 9 |
| Seroepidemiology | 9 |
| Salt | 9 |
| Saharan | 9 |
| Spanish | 9 |
| Rhino | 9 |
| RADT | 9 |
| Pulmonary | 9 |
| Programme | 9 |
| Phase | 9 |
| ≥2 | 9 |
| Hand | 8 |
| Jan | 8 |
| Islander | 8 |
| Hunan | 8 |
| Hua | 8 |
| Hospitals | 8 |
| Hangzhou | 8 |
| Guangxi | 8 |
| Hamad | 8 |
| HAV | 8 |
| GmbH | 8 |
| Ghana | 8 |
| Genetic | 8 |
| LISA | 8 |
| LH | 8 |
| MNG | 8 |
| LL | 8 |
| LY | 8 |
| Lambaréné | 8 |
| Liang | 8 |
| ML | 8 |
| MMR | 8 |
| Forces | 8 |
| Ma | 8 |
| Manual | 8 |
| Maria | 8 |
| Mother | 8 |
| NC | 8 |
| NHS | 8 |
| NO(x | 8 |
| OD | 8 |
| GL | 8 |
| 3a | 8 |
| Federation | 8 |
| CPE | 8 |
| Oxoid | 8 |
| ACT | 8 |
| AEs | 8 |
| Anti | 8 |
| BAL | 8 |
| BSI | 8 |
| BTT | 8 |
| Bank | 8 |
| British | 8 |
| Burden | 8 |
| C4 | 8 |
| CD3 | 8 |
| CLSI | 8 |
| COV-2 | 8 |
| CW | 8 |
| Effect | 8 |
| Canis | 8 |
| Census | 8 |
| Ceph | 8 |
| Child | 8 |
| Childhood | 8 |
| Class | 8 |
| Clinic | 8 |
| Cluster | 8 |
| CoNS | 8 |
| Comparative | 8 |
| Cowling | 8 |
| Database | 8 |
| Diego | 8 |
| Distress | 8 |
| Optimal | 8 |
| NI | 8 |
| P20 | 8 |
| Yamagata | 8 |
| coronaviruses | 8 |
| anti | 8 |
| alafenamide | 8 |
| Zhu | 8 |
| Z | 8 |
| Ye | 8 |
| YL | 8 |
| Units | 8 |
| Xi | 8 |
| Ward | 8 |
| W. | 8 |
| VVSJ | 8 |
| VI | 8 |
| V | 8 |
| emtricitabine | 8 |
| faecium | 8 |
| hRV | 8 |
| influenzalike | 8 |
| institutional | 8 |
| mansoni | 8 |
| obliterans | 8 |
| pancytopenia | 8 |
| phagocytophilum | 8 |
| picornavirus | 8 |
| protein | 8 |
| resp | 8 |
| sec | 8 |
| serovar | 8 |
| world | 8 |
| μmol | 8 |
| PA | 8 |
| Universal | 8 |
| difficile | 8 |
| Toxocariasis | 8 |
| Seroprevalence | 8 |
| PIV-1 | 8 |
| Toronto | 8 |
| Pathway | 8 |
| QL | 8 |
| RCT | 8 |
| Rad | 8 |
| Receiver | 8 |
| Rimuka | 8 |
| River | 8 |
| SAPS | 8 |
| SEIDR | 8 |
| SI | 8 |
| ST | 8 |
| Sepsis | 8 |
| Rio | 8 |
| Serotype | 8 |
| Strait | 8 |
| Texas | 8 |
| Test | 8 |
| Tazobactam | 8 |
| TIV | 8 |
| TET | 8 |
| Sub | 8 |
| TIBOLA | 8 |
| Standard | 8 |
| Spatial | 8 |
| Shaoxing | 8 |
| Shantou | 8 |
| Shaanxi | 8 |
| Hardy | 7 |
| Griess | 7 |
| Hantavirus | 7 |
| Hamburg | 7 |
| HRQoL | 7 |
| HN | 7 |
| HL-60 | 7 |
| HC | 7 |
| Gao | 7 |
| Gram | 7 |
| Gilead | 7 |
| Gibco | 7 |
| Genomic | 7 |
| Fukuoka | 7 |
| Galicia | 7 |
| Hi | 7 |
| Henan | 7 |
| Likert | 7 |
| IMSS | 7 |
| KL | 7 |
| Enterococcal | 7 |
| Log10 | 7 |
| Local | 7 |
| LightCycler | 7 |
| Law | 7 |
| KM | 7 |
| Jiang | 7 |
| IPA | 7 |
| Janeiro | 7 |
| JP | 7 |
| JCV | 7 |
| JA | 7 |
| Island | 7 |
| Illumina | 7 |
| Fischer | 7 |
| AA | 7 |
| Enterobacter | 7 |
| ER | 7 |
| BK | 7 |
| B19 | 7 |
| Atlanta | 7 |
| Armed | 7 |
| Antibiotic | 7 |
| Air | 7 |
| Agilent | 7 |
| Agar | 7 |
| Affairs | 7 |
| Access | 7 |
| ATCC | 7 |
| ANI | 7 |
| -HKU1 | 7 |
| -80 | 7 |
| Lu'an | 7 |
| BPL | 7 |
| BW | 7 |
| Based | 7 |
| Colombia | 7 |
| Drug | 7 |
| Douala | 7 |
| Director | 7 |
| DSMB | 7 |
| Core | 7 |
| Comprehensive | 7 |
| Co | 7 |
| Beckman | 7 |
| Cat | 7 |
| CS | 7 |
| CLI | 7 |
| CI(95 | 7 |
| CHN | 7 |
| Biosciences | 7 |
| Ltd | 7 |
| Shenzhen | 7 |
| M184V | 7 |
| Sequenom | 7 |
| bictegravir | 7 |
| antibiogram | 7 |
| Young | 7 |
| Youden | 7 |
| Xpert | 7 |
| Xinjiang | 7 |
| Wai | 7 |
| UHF | 7 |
| Tween | 7 |
| Tris | 7 |
| Thomas | 7 |
| ThermoFisher | 7 |
| Systematic | 7 |
| Summary | 7 |
| Signaling | 7 |
| clavulanic | 7 |
| coxsackie | 7 |
| department | 7 |
| piperacillintazobactam | 7 |
| ≥3 | 7 |
| MAC | 7 |
| t002 | 7 |
| syndromic | 7 |
| sulfamethoxazole | 7 |
| range | 7 |
| parainfluenzavirus | 7 |
| e. | 7 |
| omp | 7 |
| ng | 7 |
| methylprednisolone | 7 |
| meropenem | 7 |
| meningoencephalitis | 7 |
| key | 7 |
| Sigma | 7 |
| pg | 7 |
| Schwarz | 7 |
| PTGD | 7 |
| PB2 | 7 |
| PAGE | 7 |
| P<0.001 | 7 |
| P&I | 7 |
| Outcomes | 7 |
| Organ | 7 |
| Open | 7 |
| Nursing | 7 |
| Nucleic | 7 |
| Notifiable | 7 |
| NISS | 7 |
| Mannheim | 7 |
| MGAS10394 | 7 |
| MB | 7 |
| MFI | 7 |
| PCMC | 7 |
| Med | 7 |
| PVR | 7 |
| S5 | 7 |
| SS | 7 |
| Paul | 7 |
| Schiphol | 7 |
| SR | 7 |
| SAF | 7 |
| S6 | 7 |
| SP5 | 7 |
| Romania | 7 |
| Ren | 7 |
| Red | 7 |
| Pneumococcal | 7 |
| Planning | 7 |
| Peng | 7 |
| Piperacillin | 7 |
| Guizhou | 6 |
| GIS | 6 |
| GPS | 6 |
| GS | 6 |
| Guide | 6 |
| HBoV3 | 6 |
| HAP | 6 |
| HSM | 6 |
| HJB | 6 |
| HL | 6 |
| Fuller | 6 |
| HPIVs | 6 |
| Fulminant | 6 |
| FP | 6 |
| Fu | 6 |
| Freund | 6 |
| Fil | 6 |
| Figs | 6 |
| Failure | 6 |
| Faculty | 6 |
| Etiology | 6 |
| Ethiopian | 6 |
| Equipment | 6 |
| Emerging | 6 |
| ESR | 6 |
| ESKAPE | 6 |
| Hercules | 6 |
| EIP | 6 |
| Heart | 6 |
| Lankan | 6 |
| High | 6 |
| IL-1 | 6 |
| Dunn | 6 |
| MS2 | 6 |
| MODS | 6 |
| MLST | 6 |
| MIN | 6 |
| MIC | 6 |
| MI | 6 |
| MHS | 6 |
| MEC | 6 |
| MDA | 6 |
| M2 | 6 |
| Lwengo | 6 |
| Limburg | 6 |
| MTB | 6 |
| LZ | 6 |
| LW | 6 |
| LPM | 6 |
| Kaplan | 6 |
| KAP | 6 |
| Jian | 6 |
| JM | 6 |
| JL | 6 |
| Iraq | 6 |
| Instituto | 6 |
| IngeniGen | 6 |
| IL-5 | 6 |
| IL-13 | 6 |
| EHV1 | 6 |
| Austria | 6 |
| Dong | 6 |
| Direct | 6 |
| BALB | 6 |
| BACTEC | 6 |
| Application | 6 |
| Anne | 6 |
| Ann | 6 |
| Anderson | 6 |
| Amsterdam | 6 |
| Allander | 6 |
| Ali | 6 |
| Afghanistan | 6 |
| Administration | 6 |
| Addis | 6 |
| Accuracy | 6 |
| Academy | 6 |
| Ababa | 6 |
| AS | 6 |
| ARR | 6 |
| ARMS | 6 |
| AIV | 6 |
| AIC | 6 |
| AEMET | 6 |
| ABL | 6 |
| A(H3N2 | 6 |
| 18S | 6 |
| -28 | 6 |
| +874 | 6 |
| Marcy | 6 |
| BC | 6 |
| BCH | 6 |
| BKV | 6 |
| Claudia | 6 |
| Diff | 6 |
| Daxing | 6 |
| DC | 6 |
| D4 | 6 |
| Cui | 6 |
| Corp. | 6 |
| Coordination | 6 |
| Conference | 6 |
| Computing | 6 |
| Command | 6 |
| Comité | 6 |
| Clostridioides | 6 |
| Ciencias | 6 |
| BP | 6 |
| Chiu | 6 |
| Chengdu | 6 |
| Catholic | 6 |
| Cary | 6 |
| CSL | 6 |
| CM | 6 |
| CLAD | 6 |
| Builder | 6 |
| Broad | 6 |
| Biological | 6 |
| Bangkok | 6 |
| BS | 6 |
| Major | 6 |
| COVID-19-negative | 6 |
| Marie | 6 |
| Vs | 6 |
| Viridans | 6 |
| Viraffinity | 6 |
| VT | 6 |
| VP2 | 6 |
| Ureaplasmas | 6 |
| Universidad | 6 |
| Union | 6 |
| UHZ | 6 |
| Tukey | 6 |
| Trust | 6 |
| Trials | 6 |
| Transport | 6 |
| Tenofovir | 6 |
| Technologies | 6 |
| Teaching | 6 |
| Taipei | 6 |
| TOF | 6 |
| TK | 6 |
| TFX | 6 |
| TES | 6 |
| TAP | 6 |
| Syndromic | 6 |
| Swiss | 6 |
| Supplementary | 6 |
| Suizhou | 6 |
| Student | 6 |
| Step | 6 |
| Viro | 6 |
| W1 | 6 |
| St. | 6 |
| Washington | 6 |
| Mass | 6 |
| ≥10 | 6 |
| ≥1 | 6 |
| ≤14 | 6 |
| δ | 6 |
| under-5 | 6 |
| tachypnea | 6 |
| step | 6 |
| sp | 6 |
| rtRT | 6 |
| ray | 6 |
| nucleoprotein | 6 |
| mucositis | 6 |
| mArray | 6 |
| lung | 6 |
| interleukin-6 | 6 |
| df | 6 |
| des | 6 |
| administration | 6 |
| Yin | 6 |
| Yaoundé | 6 |
| YX | 6 |
| YM | 6 |
| Xie | 6 |
| XY | 6 |
| Women | 6 |
| Weinberg | 6 |
| Stefan | 6 |
| Walter | 6 |
| Spatio | 6 |
| Probe | 6 |
| Practice | 6 |
| Poland | 6 |
| Pierce | 6 |
| Peter | 6 |
| Persistence | 6 |
| Pathogen | 6 |
| Parvovirus | 6 |
| Para | 6 |
| PIV1 | 6 |
| P | 6 |
| Oxford | 6 |
| Osterhaus | 6 |
| Occupational | 6 |
| ORF | 6 |
| OC | 6 |
| Nigeria | 6 |
| Natural | 6 |
| Na | 6 |
| NT | 6 |
| NJ | 6 |
| NHSL | 6 |
| Mortality | 6 |
| Min | 6 |
| Microarray | 6 |
| Meteorological | 6 |
| Southwest | 6 |
| Meier | 6 |
| Prevalence | 6 |
| Odds | 6 |
| SB | 6 |
| Retrospective | 6 |
| Shi | 6 |
| Severity | 6 |
| Prof. | 6 |
| Seeplex | 6 |
| Sea | 6 |
| Schistosomiasis | 6 |
| Sanofi | 6 |
| SG | 6 |
| SENTRY | 6 |
| SAEs | 6 |
| SA | 6 |
| Rong | 6 |
| Reverse | 6 |
| Richard | 6 |
| Quik | 6 |
| Resplex | 6 |
| Raymond | 6 |
| Ratio | 6 |
| Profile | 6 |
| Rakai | 6 |
| RWKC | 6 |
| R0 | 6 |
| Quiha | 6 |
| Quality | 6 |
| QC | 6 |
| Qian | 6 |
| HSV | 5 |
| Hamilton | 5 |
| Guinea | 5 |
| HRVs | 5 |
| Hhospital | 5 |
| HBoV2 | 5 |
| Hans | 5 |
| ES | 5 |
| Household | 5 |
| ICD-9-CM | 5 |
| IHR | 5 |
| IL-1α | 5 |
| Grant | 5 |
| INSTI | 5 |
| Great | 5 |
| Ehrlichia | 5 |
| Gly | 5 |
| Geographic | 5 |
| Gene | 5 |
| GRA1 | 5 |
| GGOs | 5 |
| Foster | 5 |
| Form | 5 |
| Force | 5 |
| Fifth | 5 |
| Felis | 5 |
| FITC | 5 |
| Extended | 5 |
| ESAC | 5 |
| Illinois | 5 |
| IgG. | 5 |
| Maastricht | 5 |
| Incubation | 5 |
| Lambert | 5 |
| Discovery | 5 |
| Manager | 5 |
| Malaya | 5 |
| Macrolide | 5 |
| MSF | 5 |
| MRI | 5 |
| MO | 5 |
| MDRO | 5 |
| Luxembourg | 5 |
| Louis | 5 |
| Lim | 5 |
| Library | 5 |
| Liao | 5 |
| Lancet | 5 |
| LLC | 5 |
| Indigenous | 5 |
| LDA | 5 |
| LD | 5 |
| Key | 5 |
| Kang | 5 |
| Ka | 5 |
| John | 5 |
| Jinhua | 5 |
| Jilin | 5 |
| Israel | 5 |
| Ireland | 5 |
| Internal | 5 |
| Inspection | 5 |
| Inosine | 5 |
| Info | 5 |
| EAŞ | 5 |
| AMI | 5 |
| Daniel | 5 |
| Antibody | 5 |
| BioRad | 5 |
| Bern | 5 |
| Bennett | 5 |
| Belief | 5 |
| Bekämpfung | 5 |
| Bao | 5 |
| Bangladesh | 5 |
| BTS | 5 |
| BIG | 5 |
| B14 | 5 |
| Athens | 5 |
| Associated | 5 |
| Armonk | 5 |
| Anyplex | 5 |
| Allplex | 5 |
| Brazilian | 5 |
| Alignment | 5 |
| African | 5 |
| Aetiology | 5 |
| Aerosol | 5 |
| Act | 5 |
| Aboriginal | 5 |
| Abdulaziz | 5 |
| Material | 5 |
| AK | 5 |
| AFIRE | 5 |
| AF | 5 |
| A(H1N1)v | 5 |
| 3A | 5 |
| -December | 5 |
| Boards | 5 |
| Britain | 5 |
| DRB1 | 5 |
| Chile | 5 |
| DP | 5 |
| DDTS | 5 |
| DD | 5 |
| Current | 5 |
| Critical | 5 |
| Countries | 5 |
| Continuous | 5 |
| Consortium | 5 |
| Cohort | 5 |
| Coagulation | 5 |
| ClinicalTrials.gov | 5 |
| Chung | 5 |
| Christine | 5 |
| Chong | 5 |
| Cheng | 5 |
| Bronchiolitis | 5 |
| Characterization | 5 |
| Chao | 5 |
| Chang | 5 |
| Cardiac | 5 |
| Canberra | 5 |
| Canadians | 5 |
| CRD | 5 |
| CPC | 5 |
| COVID-2019 | 5 |
| COVID | 5 |
| CLR | 5 |
| CLC | 5 |
| CJS | 5 |
| CB | 5 |
| Mao | 5 |
| FL | 5 |
| Matrix | 5 |
| WW | 5 |
| anaplasmosis | 5 |
| Zoonotic | 5 |
| Zhong | 5 |
| Zhan | 5 |
| Zaire | 5 |
| Yong | 5 |
| YY | 5 |
| YT | 5 |
| Xue | 5 |
| XW | 5 |
| XT | 5 |
| William | 5 |
| Weil | 5 |
| War | 5 |
| WI | 5 |
| bioMérieux | 5 |
| WC | 5 |
| WA | 5 |
| Version | 5 |
| Vereinigung | 5 |
| Vector | 5 |
| VRTI | 5 |
| VE | 5 |
| Upper | 5 |
| UNAIDS | 5 |
| Tübingen | 5 |
| Triton | 5 |
| Township | 5 |
| Total | 5 |
| Tong | 5 |
| antigen | 5 |
| casecontrol | 5 |
| Tian | 5 |
| schistosoma | 5 |
| Maximum | 5 |
| ≥38.0 | 5 |
| ≥30 | 5 |
| ≥28 | 5 |
| ψ | 5 |
| χ2 | 5 |
| μM | 5 |
| uroliths | 5 |
| und | 5 |
| toxoplasma | 5 |
| spp | 5 |
| serologic | 5 |
| serodiagnosis | 5 |
| sentinel | 5 |
| s. | 5 |
| chloramphenicol | 5 |
| rs12711521 | 5 |
| rd | 5 |
| rabies | 5 |
| organomegaly | 5 |
| neutrophilia | 5 |
| mycobacterial | 5 |
| monacensis | 5 |
| max | 5 |
| hPeV | 5 |
| faecalis | 5 |
| del | 5 |
| control | 5 |
| cmH(2)O | 5 |
| ciprofloxacin | 5 |
| Tibet | 5 |
| | | 5 |
| Taqman | 5 |
| Nontuberculous | 5 |
| Pfizer | 5 |
| Personnel | 5 |
| Pei | 5 |
| PaO(2)/FiO(2 | 5 |
| PU | 5 |
| PIV-3 | 5 |
| PHS | 5 |
| PB1 | 5 |
| PB | 5 |
| Origin | 5 |
| OAS-1 | 5 |
| O157 | 5 |
| O | 5 |
| Northwest | 5 |
| Ngezi | 5 |
| Physicians | 5 |
| Nelson | 5 |
| NNDSS | 5 |
| Murine | 5 |
| Morbidity | 5 |
| Mongolia | 5 |
| Mohammad | 5 |
| Modelling | 5 |
| Millipore | 5 |
| Military | 5 |
| Mig | 5 |
| Methods | 5 |
| Medium | 5 |
| Tao | 5 |
| Mechanisms | 5 |
| Philippe | 5 |
| MgCl | 5 |
| Pneumofast | 5 |
| Regulations | 5 |
| Pneumoniae | 5 |
| Sloots | 5 |
| Second | 5 |
| SZ | 5 |
| SVMTriP | 5 |
| SNV | 5 |
| SMRU | 5 |
| SL | 5 |
| SKPIV4 | 5 |
| S7 | 5 |
| Rupandehi | 5 |
| Rocky | 5 |
| RhV | 5 |
| Search | 5 |
| Regulation | 5 |
| QDA | 5 |
| Post | 5 |
| RV16 | 5 |
| Prediction | 5 |
| Princess | 5 |
| Protocol | 5 |
| Puumala | 5 |
| Simplified | 5 |
| RSVB | 5 |
| Qiu | 5 |
| Qin | 5 |
| Qom | 5 |
| RIF | 5 |
| RV15 | 5 |
| Hopkins | 4 |
| H7N3 | 4 |
| Guo | 4 |
| Guidance | 4 |
| Graph | 4 |
| Genotyping | 4 |
| Gln | 4 |
| GeoDa | 4 |
| Genotype | 4 |
| Genetics | 4 |
| Gemella | 4 |
| GSS | 4 |
| HBoV1-positive | 4 |
| HMC | 4 |
| HEPA | 4 |
| HJZ | 4 |
| HP | 4 |
| HPAIVs | 4 |
| HRP | 4 |
| HWE | 4 |
| Haemorrhagic | 4 |
| Hao | 4 |
| Heilongjiang | 4 |
| Helen | 4 |
| Hens | 4 |
| GJM | 4 |
| Homozygous | 4 |
| Haemaphysalis | 4 |
| Evolutionary | 4 |
| GGC | 4 |
| GD | 4 |
| Doctor | 4 |
| Huan | 4 |
| Dongguan | 4 |
| Dosing | 4 |
| Duke | 4 |
| E- | 4 |
| EMBASE | 4 |
| EMC | 4 |
| EMR | 4 |
| EU | 4 |
| Early | 4 |
| Edition | 4 |
| Engineering | 4 |
| Environmental | 4 |
| Epidemiological | 4 |
| Eqs | 4 |
| FEV-1 | 4 |
| FMDV | 4 |
| FS | 4 |
| FT | 4 |
| Far | 4 |
| Fei | 4 |
| Fellowship | 4 |
| FilmAr | 4 |
| Florida | 4 |
| Fondazione | 4 |
| GCS | 4 |
| Hospices | 4 |
| KZ_A3 | 4 |
| Humans | 4 |
| Humoral | 4 |
| Karachi | 4 |
| Katharina | 4 |
| Kathmandu | 4 |
| Kennemerland | 4 |
| Kinetics | 4 |
| Klinikum | 4 |
| Laos | 4 |
| Lasergene | 4 |
| Lei | 4 |
| Leiden | 4 |
| Liaoning | 4 |
| Life | 4 |
| Linux | 4 |
| Liverpool | 4 |
| Ljung | 4 |
| Lombardy | 4 |
| Low | 4 |
| Lyme | 4 |
| Lymphocytopenia | 4 |
| MERS- | 4 |
| MJ | 4 |
| MN | 4 |
| Mac | 4 |
| Madison | 4 |
| Mapping | 4 |
| Mark | 4 |
| Disinfection | 4 |
| Kaohsiung | 4 |
| KSA | 4 |
| KG | 4 |
| Interval | 4 |
| IL-12 | 4 |
| IL-7 | 4 |
| IMMIC | 4 |
| INICC | 4 |
| IRR | 4 |
| ITNs | 4 |
| Incidence | 4 |
| Industrial | 4 |
| Ingenuity | 4 |
| Injury | 4 |
| Inner | 4 |
| Integrated | 4 |
| Isoprinosine | 4 |
| Johns | 4 |
| Isothermal | 4 |
| JB | 4 |
| JCX | 4 |
| JD | 4 |
| JE | 4 |
| JH | 4 |
| JHK | 4 |
| JQ | 4 |
| Jacobi | 4 |
| Java | 4 |
| Ji | 4 |
| Jia | 4 |
| DoH | 4 |
| BV | 4 |
| Ding | 4 |
| Difference | 4 |
| Aldrich | 4 |
| Analyzer | 4 |
| Andrea | 4 |
| Andreas | 4 |
| Angiotensin | 4 |
| Anonymous | 4 |
| Anthony | 4 |
| Antibiotics | 4 |
| Antiviral | 4 |
| Antonio | 4 |
| Anxiety | 4 |
| Applications | 4 |
| Approval | 4 |
| Arabian | 4 |
| Asian | 4 |
| Australians | 4 |
| Ayder | 4 |
| B*0703 | 4 |
| BA | 4 |
| BCR | 4 |
| BJ | 4 |
| BJC | 4 |
| BNP | 4 |
| BRO | 4 |
| BVDV | 4 |
| Bacteria | 4 |
| Barcelona | 4 |
| Alb | 4 |
| Alafenamide | 4 |
| Akaike | 4 |
| AMR | 4 |
| May. | 4 |
| -1 | 4 |
| -28C | 4 |
| -3 | 4 |
| 2c | 4 |
| A(H5N1 | 4 |
| ABOS | 4 |
| AC | 4 |
| ACF | 4 |
| ACIP | 4 |
| AKI | 4 |
| AL | 4 |
| ANK | 4 |
| Age | 4 |
| APTT | 4 |
| AQSIQ | 4 |
| ARIwC. | 4 |
| AW | 4 |
| AYG | 4 |
| Academic | 4 |
| Acquired | 4 |
| Acquisition | 4 |
| Activity | 4 |
| Additional | 4 |
| Adobe | 4 |
| Adult | 4 |
| Baseline | 4 |
| Basic | 4 |
| Bayesian | 4 |
| DN | 4 |
| Code | 4 |
| Company | 4 |
| Congo | 4 |
| Copenhagen | 4 |
| Corp | 4 |
| Correlate | 4 |
| Coulter | 4 |
| Cov | 4 |
| Cov-2 | 4 |
| Criterion | 4 |
| Cruz | 4 |
| Cuba | 4 |
| DSS | 4 |
| Claire | 4 |
| DTG | 4 |
| DU | 4 |
| Dai | 4 |
| Dalian | 4 |
| Darmstadt | 4 |
| Defense | 4 |
| Definitions | 4 |
| Delta | 4 |
| Demographic | 4 |
| Deng | 4 |
| Dermacentor | 4 |
| Deutschen | 4 |
| Clark | 4 |
| Cl | 4 |
| Bellman | 4 |
| Cai | 4 |
| Benjamin | 4 |
| Bictegravir | 4 |
| Bing | 4 |
| Borne | 4 |
| Boston | 4 |
| Brescia | 4 |
| CA16 | 4 |
| CLL | 4 |
| CONSORT | 4 |
| CPK | 4 |
| CTL | 4 |
| CTX | 4 |
| Canadian | 4 |
| Civils | 4 |
| Capital | 4 |
| Cardiology | 4 |
| Carlsbad | 4 |
| Carrier | 4 |
| Caspian | 4 |
| Catalonia | 4 |
| Cepheid | 4 |
| Charlson | 4 |
| Choi | 4 |
| Chow | 4 |
| Christian | 4 |
| Christiane | 4 |
| Matlab | 4 |
| Umrah | 4 |
| Mean | 4 |
| empyema | 4 |
| XunMinKang | 4 |
| YC | 4 |
| YS | 4 |
| Yangtze | 4 |
| Yearbook | 4 |
| Yonsei | 4 |
| Yun | 4 |
| ZX | 4 |
| Zeng | 4 |
| Zhi | 4 |
| acyclovir | 4 |
| aeruginosa | 4 |
| agar | 4 |
| allantoic | 4 |
| altona | 4 |
| aplasia | 4 |
| aureus | 4 |
| bacillary | 4 |
| baculovirus | 4 |
| buffy | 4 |
| burgdorferi | 4 |
| calcoaceticus | 4 |
| carbapenem | 4 |
| cross | 4 |
| cytopenia | 4 |
| darunavir | 4 |
| dolutegravir | 4 |
| Xuan | 4 |
| Xizang | 4 |
| 4 | |
| VZV | 4 |
| Territories | 4 |
| Theo | 4 |
| Thrombocytopenia | 4 |
| Transmissibility | 4 |
| UL97 | 4 |
| URT | 4 |
| UTM | 4 |
| ≥75 | 4 |
| Univariate | 4 |
| VIG | 4 |
| VLM | 4 |
| VWR | 4 |
| Vero | 4 |
| XP | 4 |
| Veterans | 4 |
| ViiV | 4 |
| Viruskrankheiten | 4 |
| Vitek | 4 |
| Vulpes | 4 |
| WB | 4 |
| WK | 4 |
| WZ | 4 |
| Weber | 4 |
| Winter | 4 |
| Writing | 4 |
| Wyeth | 4 |
| dysfunction | 4 |
| excavation(s | 4 |
| Task | 4 |
| fumarate | 4 |
| picogram | 4 |
| picornaviruses | 4 |
| pneumonia | 4 |
| pneumovirus | 4 |
| protease-2 | 4 |
| recombinase | 4 |
| recruit | 4 |
| red | 4 |
| rhinorrhea | 4 |
| ribavirin | 4 |
| ritonavir | 4 |
| rt | 4 |
| sH3N2 | 4 |
| subgenotype | 4 |
| type | 4 |
| unter | 4 |
| upE | 4 |
| urban | 4 |
| vancomycin | 4 |
| vulpes | 4 |
| zanamivir | 4 |
| Δ | 4 |
| μL | 4 |
| π | 4 |
| ≥37.5 | 4 |
| ≥38 | 4 |
| Mef(A | 4 |
| pdm | 4 |
| paratyphoid | 4 |
| nucleocapsid | 4 |
| jackal | 4 |
| g. | 4 |
| genotype | 4 |
| gonorrhoeae | 4 |
| granulocytic | 4 |
| h. | 4 |
| haemodialysis | 4 |
| http:// | 4 |
| hyperferritinemia | 4 |
| imipenem | 4 |
| immunoassays | 4 |
| influenzavirus | 4 |
| interferon | 4 |
| leptospira | 4 |
| nd | 4 |
| leukocidin | 4 |
| leukocytosis | 4 |
| lobar | 4 |
| longicornis | 4 |
| mL. | 4 |
| mM | 4 |
| malaria | 4 |
| mannan | 4 |
| mass | 4 |
| metapneumo | 4 |
| mmol | 4 |
| myalgia | 4 |
| Terminal | 4 |
| time | 4 |
| Takara | 4 |
| RMSE | 4 |
| PPD | 4 |
| PSQI | 4 |
| Paisley | 4 |
| Panbio | 4 |
| Paramyxoviridae | 4 |
| PathoFinder | 4 |
| Pathogens | 4 |
| Penicillin | 4 |
| Perry | 4 |
| Personal | 4 |
| Pertussis | 4 |
| Platinum | 4 |
| PoC | 4 |
| Point | 4 |
| Pooling | 4 |
| Positive | 4 |
| Primary | 4 |
| Principles | 4 |
| Progress | 4 |
| Protein | 4 |
| Prothrombin | 4 |
| Python | 4 |
| QIAGEN | 4 |
| Quantitation | 4 |
| Quantitative | 4 |
| R1 | 4 |
| RA | 4 |
| PLT | 4 |
| PK | 4 |
| PID | 4 |
| NLF | 4 |
| Metagenomic | 4 |
| Taiwanese | 4 |
| Methicillin | 4 |
| Mexican | 4 |
| Mix | 4 |
| Mohamed | 4 |
| Mountain | 4 |
| MxA | 4 |
| NCP | 4 |
| NIAID | 4 |
| NIOSH | 4 |
| NIs | 4 |
| NP-1 | 4 |
| PDR | 4 |
| NTA | 4 |
| Nanjing | 4 |
| Nationwide | 4 |
| NetCTL1.2 | 4 |
| Non | 4 |
| Nov | 4 |
| O43 | 4 |
| OSHA | 4 |
| Operating | 4 |
| Operator | 4 |
| PCV-7 | 4 |
| PCoA | 4 |
| RFCID | 4 |
| Multisystem | 4 |
| Rabies | 4 |
| Sung | 4 |
| Shiraz | 4 |
| Silva | 4 |
| Simon | 4 |
| Simulation | 4 |
| Simulator | 4 |
| Situation | 4 |
| Sparks | 4 |
| Special | 4 |
| Specialized | 4 |
| Spread | 4 |
| Strongyloides | 4 |
| Su10 | 4 |
| Susceptibility | 4 |
| Shen | 4 |
| Syncytial | 4 |
| Sysmex | 4 |
| TA | 4 |
| TCDC | 4 |
| TDS | 4 |
| TGME49_073130_2 | 4 |
| THK | 4 |
| TN | 4 |
| TNFα | 4 |
| TW | 4 |
| Recherche | 4 |
| TT | 4 |
| Sheng | 4 |
| TIB | 4 |
| Serum | 4 |
| SMNG | 4 |
| Rotavirus | 4 |
| Serotypes | 4 |
| S10 | 4 |
| Redmond | 4 |
| S13 | 4 |
| SAG1 | 4 |
| SE | 4 |
| SELDI | 4 |
| SEM | 4 |
| SH | 4 |
| SM | 4 |
| SMH | 4 |
| S11 | 4 |
| Rhinoviruses | 4 |
| SXT | 4 |
| Seegene | 4 |
| SMR | 4 |
| Scale | 4 |
| Sampling | 4 |
| Season | 4 |
| Seattle | 4 |
| SSTI | 4 |
| SQ | 4 |
| SNE | 4 |
| SOFA | 4 |
| SW | 4 |
| IRS | 3 |
| IP | 3 |
| IPTG | 3 |
| IRCCS | 3 |
| Immunology | 3 |
| ITT | 3 |
| IgA | 3 |
| IgG1 | 3 |
| INA | 3 |
| Immunodeficiency | 3 |
| Idaho | 3 |
| HiTrap | 3 |
| IHE | 3 |
| IEDB | 3 |
| ICH | 3 |
| ICD-9 | 3 |
| Hypercube | 3 |
| Hydropotes | 3 |
| Huo | 3 |
| Hospitalized | 3 |
| Hospitalizations | 3 |
| Hodgkin | 3 |
| Immunosenescence | 3 |
| Hiroshi | 3 |
| IATA | 3 |
| Intermittent | 3 |